Vicapsys Life Sciences, Inc. (VICP)

OTCMKTS · Delayed Price · Currency is USD
1.500
0.00 (0.00%)
At close: Dec 3, 2025
Market Cap48.56M
Revenue (ttm)n/a
Net Income-1.35M
EPS-0.04
Shares Out32.37M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume824
Average Volume657
Open1.500
Previous Close1.500
Day's Range1.500 - 1.500
52-Week Range0.000 - 3.000
Beta453,881.05
RSI46.04
Earnings DateApr 16, 2026

About Vicapsys Life Sciences

Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN, a proprietary product. The company’s product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics Internati... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol VICP
Full Company Profile

Financial Performance

Financial Statements